Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Par Pharmaceutical, Inc.

Par Pharmaceutical, Inc. Recalls

All product recalls associated with Par Pharmaceutical, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

303

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 2141–2160 of 4747 recalls

Mycophenolate Mofetil Injection (Par) – Glass Fragment (2019)

Presence of Particulate Matter; glass fragment observed in one vial of reconstituted product

Class IHigh

FDAApr 30, 2019Nationwide• Par Pharmaceutical, Inc.

Carvedilol Tablets (Zydus) – Label Mix-up (2019)

Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg

Class IIModerate

FDAApr 25, 2019Nationwide• Zydus Pharmaceuticals USA Inc

Acyclovir Tablets (Zydus) – Label Mix-up (2019)

Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg

1...106 107108109 110...238

Page 108 of 238Next

Class II

Moderate

FDAApr 25, 2019Nationwide• Zydus Pharmaceuticals USA Inc

Dermoplast Spray (Advantice Health) – Incorrect Weight Label (2019)

Labeling: Not Elsewhere Classified: canisters incorrectly state the net weight is 2.75 oz. rather than the correct net weight of 2.0 oz.

Class IIILow

FDAApr 25, 2019Nationwide• Advantice Health

Dermoplast Spray (Advantice Health) – Incorrect Weight Label (2019)

Labeling: Not Elsewhere Classified: Full cases may contain canisters that incorrectly state the net weight is 2.75 oz. rather than the correct net weight of 2.0 oz.

Class IIILow

FDAApr 25, 2019Nationwide• Advantice Health

Losartan Potassium Tablets (Legacy) – NMBA Impurity (2019)

CGMP Deviations: Detection of trace amounts of N-Methylnitrosobutyric acid (NMBA) impurity found in the Active Pharmaceutical Ingredient (API)

Class IIModerate

FDAApr 24, 2019AZ, TN• Legacy Pharmaceutical Packaging LLC

Divalproex Sodium Tablets (Major Pharmaceuticals) – Humidity Exposure (2019)

cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.

Class IIModerate

FDAApr 24, 2019Nationwide• MAJOR PHARMACEUTICALS

Carvedilol Tablets (Zydus Pharmaceuticals) – Foreign Tablet Contamination (2019)

Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg.

Class IIILow

FDAApr 22, 2019Nationwide• Zydus Pharmaceuticals USA Inc

Philips Healthcare Informatics, Inc.: IntelliSpace PACS 4.4, Product number 837507 - Product Us...

Images may potentially become corrupt while using the system.

FDAApr 19, 2019Nationwide• Philips Healthcare Informatics, Inc.

Snowmobiles (Arctic Cat) – fire hazard (2019)

Fire/Burn Risk

This recall involves all Model Year 2018 and 2019 Arctic Cat snowmobile models M8000, XF8000, ZR8000, and Norseman X8000. The vehicles were produced in a variety of color combinations and track lengths. The vehicles all have 8000 on each side of the front hood/side panel area and ARCTIC CAT on the rear snow-flap. The vehicle identification number (VIN) is stamped on the right side of the snowmobile tunnel near the right foot rest.

CPSCApr 18, 2019Nationwide• Arctic Cat Inc., of Thief River Falls, Minn.

Volumex Injection (Iso-Tex) – Sterility Concerns (2019)

Lack of Assurance of Sterility: environmental monitoring report exceeds limits, therefore sterility cannot be assured.

Class IIModerate

FDAApr 15, 2019TN• Iso-Tex Diagnostics, Inc

Amoxicillin Suspension (Teva) – Subpotent Product (2019)

Subpotent Product: assay results for Amoxicillin were below the specification limits.

Class IIModerate

FDAApr 12, 2019Nationwide• Teva Pharmaceuticals USA